I. Harukuni et al., sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion, STROKE, 31(4), 2000, pp. 976-981
Background and Purpose-We previously showed that the intravenous administra
tion of the potent sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-pipe
ridine (PPBP) provides neuroprotection against transient focal cerebral isc
hemia and that the protection depends on treatment duration. We tested the
hypothesis that PPBP would provide neuroprotection in a model of transient
focal ischemia and 7 days of reperfusion in the rat as assessed with neurob
ehavioral outcome and infarction volume.
Methods-Under the controlled conditions of normoxia, normocarbia, and normo
thermia, halothane-anesthetized male Wistar rats were subjected to 2 hours
of middle cerebral artery occlusion (MCAO) with the intraluminal suture occ
lusion technique. We used laser Doppler flowmetry to assess MCAO, At 60 min
utes after the onset of ischemia, rats were randomly assigned to 1 of 4 tre
atment groups in a blinded fashion and received a continuous intravenous in
fusion of control saline or 0.1, 1, or 10 mu mol . kg(-1) . h(-1) PPBP for
24 hours. Neurobehavioral evaluation was performed at baseline (3 to 4 days
before MCAO) and at 3 and 7 days of reperfusion. Infarction volume was ass
essed with triphenyltetrazolium chloride staining on day 7 of reperfusion i
n all rats.
Results-Triphenyltetrazolium chloride-determined infarction volume of ipsil
ateral cortex was smaller in rats treated with 10 mu mol . kg(-1) . h(-1) P
PBP (n=15, 68+/-12 mm(3), 18+/-3% of contralateral structure, P<0.05) (mean
+/-SEM) compared with corresponding rats treated with saline (n=15, 114+/-1
1 mm(3), 31+/-3% of contralateral structure). PPBP did not provide signific
ant neuroprotection in the caudoputamen complex. Although MCAO was associat
ed with several alterations in behavior, the treatment with PPBP had no eff
ect on behavioral outcomes.
Conclusions-The data demonstrate that the potent sigma(1)-receptor ligand P
PBP decreases cortical infarction volume without altering neurobehavior aft
er transient focal ischemia and prolonged reperfusion in the rat.